Form 8-K - Current report:
SEC Accession No. 0001558370-24-012775
Filing Date
2024-09-13
Accepted
2024-09-13 16:16:28
Documents
13
Period of Report
2024-09-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20240910x8k.htm   iXBRL 8-K 44687
  Complete submission text file 0001558370-24-012775.txt   169372

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20240910.xsd EX-101.SCH 3249
3 EX-101.LAB xlo-20240910_lab.xml EX-101.LAB 16578
4 EX-101.PRE xlo-20240910_pre.xml EX-101.PRE 10708
15 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240910x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 241297949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)